MSK Tracker

  • Research type

    Research Study

  • Full title

    Implementing the MSK-HQ to empower patients and improve services

  • IRAS ID

    237571

  • Contact name

    Clark Crawford

  • Contact email

    research.governance@keele.ac.uk

  • Sponsor organisation

    Keele University

  • Clinicaltrials.gov Identifier

    NCT03559205

  • Duration of Study in the UK

    1 years, 11 months, 31 days

  • Research summary

    This study will co-design and test the feasibility and impact of implementing the Arthritis Research UK Musculoskeletal Health Questionnaire (MSK-HQ) using an e-PROM (electronic Patient Reported Outcome Measure) delivered via a digital health platform, with innovative embedded components called the MSK-Tracker. The MSK-Tracker uses the MSK-HQ as a foundation to help patients with MSK pain to:
    • track the extent to which they are affected by their MSK condition across different aspects of their health,
    • prepare appropriately for their clinical encounters, and
    • take the right steps to making positive changes to improve their quality of life and manage their condition over the longer-term.

    The study will test the ability of the MSK Tracker to act as an empowerment tool and method of facilitating a person-centred care planning approach in routine MSK consultations. The study will also assess the value of the MSK Tracker in generating aggregated outputs to inform service improvement.

    We will use a before and after single Centre design with the comparator between phases 1 and 3 across a range of outcomes. Phase 2 will focus on iterative testing of the MSK-Tracker.

    In addition, in Phase 1 and 3 we will undertake qualitative research using the Experience Based Co-Design (EBCD) methodology to explore the impact of the MSK-Tracker and to inform further improvement and refinement of the tool and its use within the context of an MSK service and clinical practice. The findings from the qualitative research will be triangulated with insights from the aggregated data of patient outcomes to enrich and help make sense of the study findings.

  • REC name

    North West - Greater Manchester West Research Ethics Committee

  • REC reference

    18/NW/0244

  • Date of REC Opinion

    1 May 2018

  • REC opinion

    Further Information Favourable Opinion